在美国非糖尿病人群中,多次接触农药和血糖调节受损
Xingdi Zhu1, Congxin Chen2, Qi Liu2
1Department of Obstetrics and Gynecology, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, 210004, China; First School of Clinical Medicine, Nanjing Medical University, Nanjing, 211100, China.
Environmental pollution (Barking, Essex : 1987)
|December 13, 2024
概括
农药暴露,特别是有机农药 (OPs),与美国成年人的葡萄糖调节受损和糖尿病前期有关. 这种联系在老年人中更强烈,这表明早期糖尿病预防策略的潜力.
科学领域:
- 环境健康 环境健康
- 代谢障碍 代谢障碍 代谢障碍
- 毒理学 毒理学 毒理学
背景情况:
- 糖尿病前期是一种重要的代谢障碍,经常被忽视,患2型糖尿病的进展率很高.
- 农药的糖尿病效应是众所周知的,但它们与糖尿病前期的联系仍未得到充分研究.
- 调查农药暴露对于了解和预防不断升级的糖尿病流行病至关重要.
研究的目的:
- 评估在美国非糖尿病人群中暴露于常见的尿路农药和受损葡萄糖调节 (IGR) 之间的关联.
- 专门研究有机农药 (OPs),铁,除草剂和糖尿病前期,包括胰岛素耐药性之间的关系.
主要方法:
- 对三个类型的尿路农药进行分析:有机农药 (OPs), pyrethroids 和除草剂.
- 使用了通用线性回归,受限立方线和贝叶斯内核机器回归 (BKMR) 模型.
- 评估糖尿病前期 (禁食葡萄糖[IFG]和/或葡萄糖耐受性[IGT]) 和胰岛素抵抗.
主要成果:
- 3,5,6-三烯醇 (TCPY) 与糖尿病前期和葡萄糖耐受性损害 (IGT) 有积极的线性关联.
- 马拉二酸 (MDCA) 和帕拉尼托芬醇 (PNP),这两种OP代谢物,与胰岛素耐药性增加的几率有关.
- 在混合物暴露分析中,TCPY,MDCA和PNP是主要的贡献者;随着年龄的增长,关联变得更加明显.
结论:
- 研究结果表明,有机农药暴露与葡萄糖调节受损之间存在显著关系,特别是在老年人中.
- 这项研究强调了农药暴露在糖尿病发展早期的潜在作用.
- 通过解决环境暴露,结果为针对2型糖尿病的有针对性的预防策略提供了见解.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes: Symptoms, Diagnosis, and Complications
504
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
504
Oral Hypoglycemic Agents: Biguanides and Glitazones
172
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
172
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Pathophysiology of Diabetes
866
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
866
Dipeptidyl Peptidase 4 Inhibitors
171
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
171


